Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1146-1147, 2007-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Omalizumab: First report of anaphylaxis: case report
Reactions Weekly, Vol. 1, Iss. 1099, 2006-01 ,pp. :
Tadalafil: First report of anaphylaxis: case report
Reactions Weekly, Vol. 1, Iss. 1092, 2006-01 ,pp. :
Ecallantide: First report of anaphylaxis: case report
Reactions Weekly, Vol. 1, Iss. 1094, 2006-01 ,pp. :
Exenatide: First report of anaphylaxis: case report
Reactions Weekly, Vol. 1, Iss. 1189, 2008-01 ,pp. :
Telithromycin: First report of anaphylaxis: case report
Reactions Weekly, Vol. 1, Iss. 1141, 2007-01 ,pp. :